Quick Answer
Definium Therapeutics, Inc. reported Common Stock Shares Outstanding of 98.78 million shares for the year ending 2025.
- Definium Therapeutics, Inc. showed an increase of +31.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Definium Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Definium Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 251.2%.
- Historical annual values: Fiscal year 2025: 98.78 million shares | Fiscal year 2024: 75.10 million shares | Fiscal year 2023: 41.10 million shares | Fiscal year 2022: 37.98 million shares | Fiscal year 2021: 28.13 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: